Stockreport

Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Monopar Therapeutics Inc.  (MNPR) 
PDF WILMETTE, Ill., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovativ [Read more]